MedPath

Evaluation of a new and simple diagnostic test for malaria

Phase 3
Conditions
Malaria (uncomplicated Plasmodium falciparum malaria)
Infections and Infestations
Registration Number
ISRCTN13334317
Lead Sponsor
Academic Medical Center
Brief Summary

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36048775/ (added 02/09/2022)

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
4541
Inclusion Criteria

In Sudan, Ethiopia, Burkina Faso and Kenya, the study will include patients who fulfil the following inclusion criteria:
1. Potential participant (patients with clinical suspicion of malaria) of all ages presenting at the health facility;
2. Coming from the health centre catchment area;
3. Informed consent from patient or of parents/guardians (in case of minors).
In Namibia, the study will include persons who fulfil the following criteria:
1. Be a resident of one of the selected households or have slept the night before in this household.
2. Informed consent from potential participants (individually).

Exclusion Criteria

Not meeting the above inclusion criteria, depending on study site.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath